Leaders | Recep for trouble

Lessons from Turkey on the evils of high inflation

It hurts investment and makes most people poorer

A vendor waits for customers at a food shop, in Ankara, Turkey, Thursday, Jan. 20, 2022. Turkey's central bank kept a key interest rate unchanged on Thursday, halting a string of rate cuts that triggered a currency crisis and sent prices skyrocketing. Inflation in Turkey surged 36% last month - reaching a 19-year high and leaving many in the country of nearly 84 million struggling to buy food and other basic goods.(AP Photo/Burhan Ozbilici)

It took for ever and then it took a night. That was how Rudiger Dornbusch, an influential economist who died in 2002, described the gestation of a financial crisis. In the Dornbusch telling, booms go on for much longer than seems rational or possible before they end with a speed that also surprises. The unsustainable can be sustained for longer than you would think.

This article appeared in the Leaders section of the print edition under the headline “Turkey shoot”

ESG: Three letters that won’t save the planet

From the July 23rd 2022 edition

Discover stories from this section and more in the list of contents

Explore the edition

More from Leaders

Keir Starmer surrounded by the Eu stars

Sir Keir Starmer should aim higher in his reset with the EU

And he needs to be clearer about what Britain wants

illustration of a world map outlined by a single red electrical cord, with a plug at one end and a socket at the other

To make electricity cheaper and greener, connect the world’s grids

Less than 3% of the world’s power is internationally traded—a huge wasted opportunity


Chinese AI is catching up, posing a dilemma for Donald Trump

The success of cheap Chinese models threatens America’s technological lead


America has an imperial presidency

And in Donald Trump, an imperialist president for the first time in over a century

Tariffs will harm America, not induce a manufacturing rebirth

Donald Trump’s pursuit of tariffs will make the world poorer—and America, too 

How to improve clinical trials

Involving more participants can lead to new medical insights